Skip to main content
NRSN logo

NRSN · NeuroSense Therapeutics Ltd.

$0.59 -0.06 (-9.36%) At close · Jul 24
Market Cap
$21.74M
Shares
36.10M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 12
Total Value: $256,459
Total Shares: 339,700

Institutional Ownership Trend

19 quarters

Holder Concentration

Across 13 13F filers
Top Holder
20.5%
Jun 2023 → Mar 2026 · range 20.5% – 94.8%
of institutional value
Top 5
68.9%
Jun 2023 → Mar 2026 · range 68.9% – 100.0%
of institutional value
Top 10
96.5%
Jun 2023 → Mar 2026 · range 93.8% – 100.0%
of institutional value
HHI
1,181
Jun 2023 → Mar 2026 · range 1,181 – 8,994
Broadly held
Showing 12 of 12
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1875091 CUSIP M74240108 13F (30d) 1 filings 1 filers Visit website Investor relations